Brainlab Acquires VisionTree to Drive Patient-Reported Outcomes

Brainlab is a digital medical technology company. Today (January 22, 2020) the company announced the recent acquisition of VisionTree Software, Inc., a San Diego based company that develops cloud-based, patient-centric data collection and health management solutions.

The acquisition to Acquires VisionTree re-emphasizes the Brainlab commitment to quantifying medical procedure outcomes by taking a closer look at patients’ quality of life and condition after treatment. Brainlab investment into integrating objective measures into critical interventions follows the trend acknowledged by payers and providers from a fee-for-service towards a fee-for-value healthcare system.

Brainlab software today is digitally entrenched in a growing number of critical treatment workflows, generating a unique array of structured, validated, digital data. This workflow data is correlated with detailed anatomical data, stemming from the unique anatomical mapping capabilities of Brainlab. The results are powerful clinical registries with a wealth of otherwise hardly accessible data.

This effort is now enhanced by VisionTree in three ways:

  1. The company’s extensive experience in providing tools and standardized forms for collecting granular and well-structured outcomes data directly from consenting patients: More than 600 global healthcare providers and 2.5 million patients already rely on the VisionTree ePRO technology
  2. The VisionTree Optimal Care (VTOC) platform has proven integration capabilities with leading electronic health record (EHR), research and registry platforms
  3. VisionTree technology will allow the capture of semantically structured data otherwise only available in text format by using point-of-care electronic forms i.e. patient demographics during patient admission entered on a tablet PC

The established ePRO solution will complement the Brainlab cloud-based infrastructure and registry solution aiming to deliver patient engagement and even more comprehensive quality reporting. This will not only increase the quality and depth of data, but also further automate the data collection process while widening the company’s reach. Brainlab is committed to establishing a digital benchmark for medical data registries including medical image data to create a new standard for quality of care, quality control and research.

“I believe that patient data must ultimately be controlled by the patient. The acquisition of VisionTree adds a tool to our portfolio that will give the patient more control over the data that is generated by our systems for the benefit of better treatment,” said Stefan Vilsmeier, Brainlab President and Chief Executive Officer.

Brainlab will continue to invest in the VTOC platform aiming to facilitate data collection across all available sources including smart devices and wearables. At the same time, Brainlab will further enhance the VisionTree patient portal and enable patients to control the handling and processing of their data. By combining VTOC with its unique software ecosystem, Brainlab plans to offer streamlined and paperless workflows that combine patient-reported outcomes with anatomical information, treatment plans and surgical events to its more than 5,000 customers worldwide. Such unique aggregation of information along the digital data journey will open up new horizons for registries, clinical trials and all clinicians that believe in the potential of big data to improve treatments.

SourceBrainlab
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Kleiner Device Labs will attend the meeting and looks forward to demonstrating the new KG®2 Surge® flow-thru interbody system to surgeons
“Medtronic is continuing our efforts to stop Axonics from profiting off of their unauthorized use of our innovations and intellectual property," said Mira Sahney, president of the pelvic health business in the neuroscience portfolio at Medtronic. "The pattern is clear: Axonics uses Medtronic technologies to improperly compete in the market. It is time for Axonics to be held accountable for these unlawful acts."
The addition of Frank J Veith, MD to the Board underscores ViTAA's commitment to excellence and innovation in the development of medical technologies. His vast experience and achievements will provide critical insights and direction as ViTAA continues to pursue its goal of revolutionizing patient care through cutting-edge solutions.
Ultralife Corporation will join forces with cart manufacturer Karta to launch a complete medical cart and power solution on booth 1237 (Hall A) at HIMSS, from March 12-14, 2024 at the Orange County Convention Center in Orlando, Florida.
“It’s exciting to be one of the first two hospitals in Europe to use Stryker’s Mixed Reality Guidance System,” said Professor Berhouet. “I am also pleased to be leading a pilot study to investigate the safety and effectiveness of this new technology, alongside three other centres in France.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy